Therapeutic strategies for COVID-19 patients are complex, and so the synergistic effects of BTK, FLT3, and EGFR in ALI should also be highlighted in the development of broad-spectrum antiviral compounds that boost the innate response. This evidence concerns the gene BTK and COVID-19.